2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model
| Autor: | Salah, S., Kobayashi, T., Ito, K., Kita, Y., Horani, M., Alshangiti, A., Abu Hijlih, R., Sammour, M., Abuhijla, F., Al-Rabi, K. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1159-S1159 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|